Servier

Servier Welcome to our page. Servier is committed to therapeutic progress to serve patient needs.

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion.

----

To report a suspected adverse event with a Servier drug 👉 https://bit.ly/435zpoI

23/02/2026

💬 “I really enjoy collaboration. I think it’s amazing to feel that we are all partnering to move towards a common objective, a common goal.”

Meet Ekaterina (Katia) Trunova, formerly Global Forecast and Market Insights Director for Cardio-Metabolic and Venous Diseases at Servier, and now promoted to Business Office Director – Cardio-Metabolism.

📊 With a background in market research and strategic insights, Katia helps teams make data-driven decisions that shape Servier’s long-term strategy, forecasting up to ten years ahead while staying closely connected to teams across the organization.

🤝 What motivates her most is teamwork: the shared sense of purpose, the energy of collaboration, and the opportunity to grow and learn alongside inspiring colleagues every day.

22/02/2026

💬 “Being part of this patient commitment, working in a company that is truly committed to patients, is amazing.”

💊 Meet Liliana Alvarado, who began her career in environmental science before finding her purpose in healthcare and joining Servier in 2013.

❤️👩‍⚕️ As part of the cardiovascular team, she leads marketing and promotional strategy, working hand in hand with global and local colleagues to align every initiative with the needs of patients and healthcare professionals.

What drives her every day? The energy of teamwork, the impact of meaningful projects, and the pride of contributing to Servier’s mission to improve lives around the world.

21/02/2026

❓ Did you know that a medicine doesn't become approved and then it's all done? This is the start of continuous safety monitoring in real-world conditions.

📊 In this episode, we're going to talk about pharmacovigilance. That's the process of tracking a drug's safety, detecting rare side effects, and adapting recommendations as new data emerges. Patients can help by letting us know if they have any unexpected effects.

🩺 Even after launch, Phase 4 clinical trials continue to assess long-term safety and new potential uses. This ensures that patients always receive the safest and most effective care.

🔎 Stay tuned to discover the final stage of the life-cycle of a medicine

20/02/2026

💡 Yesterday was World Cholangiocarcinoma Day!

💡Cholangiocarcinoma is a rare and aggressive bile duct , often linked to a specific medical history.

Check out our video about the 3 things to keep in mind about cholangiocarcinoma 👇

Learn more about cholangiocarcinoma at 👉 https://bit.ly/42Is3sW

🌍 Cholangiocarcinoma is a rare and aggressive cancer of the bile ducts. Understanding treatment options is key to giving...
20/02/2026

🌍 Cholangiocarcinoma is a rare and aggressive cancer of the bile ducts. Understanding treatment options is key to giving hope and improving outcomes.

✅ What treatments are available?

📌 Surgery: The only potentially curative option, but possible for a limited number of patients.
📌 Chemotherapy: Helps slow disease progression when surgery isn’t an option.
📌 Immunotherapy & Targeted Therapies: Innovative approaches to fight cancer and improve quality of life.

💡 Early diagnosis and research are essential to offer more possibilities for patients.

Learn more about cholangiocarcinoma at 👉 https://bit.ly/42Is3sW

19/02/2026

💡 Today is World Cholangiocarcinoma Day

🔬 What are the risk factors associated with cholangiocarcinoma?

Various risk factors are associated with cholangiocarcinoma:
➡️ A history of previous disease or irritation of the bile ducts
➡️ Age (> 70 years old)
➡️ Obesity
➡️ Diabetes
➡️ Exposure to certain types of chemicals

Learn more about cholangiocarcinoma at 👉 https://bit.ly/42Is3sW

🎗️ 🟣 Today is World Cholangiocarcinoma Day!Cholangiocarcinoma, or bile duct cancer, is often diagnosed late because earl...
19/02/2026

🎗️ 🟣 Today is World Cholangiocarcinoma Day!

Cholangiocarcinoma, or bile duct cancer, is often diagnosed late because early symptoms are non-specific:
✔ Fatigue
✔ Abdominal pain
✔ Unexplained weight loss

More specific signs, like jaundice, usually appear when the disease is already advanced.

Early detection is challenging, but awareness can make a difference. 💜

Learn more about cholangiocarcinoma at 👉 https://bit.ly/42Is3sW

💡 Tomorrow is World Cholangiocarcinoma Day👥 In the US, there are an estimated 8,000 new cases of cholangiocarcinoma each...
18/02/2026

💡 Tomorrow is World Cholangiocarcinoma Day

👥 In the US, there are an estimated 8,000 new cases of cholangiocarcinoma each year.
In Asia, cholangiocarcinoma has a higher occurrence rate because of the presence of a parasitic worm that infects the liver and bile ducts.

To learn more, please visit 👉 https://bit.ly/42Is3sW

💡 World Cholangiocarcinoma Day is coming!Also known as bile duct cancer, it's a rare and aggressive tumour.The first sig...
18/02/2026

💡 World Cholangiocarcinoma Day is coming!

Also known as bile duct cancer, it's a rare and aggressive tumour.
The first signs are often non-specific, making it a challenging condition to diagnose and treat.

Learn more about cholangiocarcinoma at 👉 https://bit.ly/42Is3sW

The future of science is diverse — and today, we honor the women at Servier who innovate, explore, and shape tomorrow’s ...
12/02/2026

The future of science is diverse — and today, we honor the women at Servier who innovate, explore, and shape tomorrow’s discoveries.
Their passion fuels our mission and reminds us why this UNESCO led day matters more than ever.

For them, STEM rhymes with Alliance, Curiosity, Guidance, Velocity, Passion & transmission.

👉 And for you — Science, Technology, Engineering and Mathematics rhyme with… ? Drop your answer in the comments!

Behind every breakthrough stands a team of talented minds — and countless women whose expertise and leadership ignite pr...
11/02/2026

Behind every breakthrough stands a team of talented minds — and countless women whose expertise and leadership ignite progress.

On this International Day of Women and Girls in Science, we’re proud to spotlight the Servier collaborators who embody excellence in STEM.

For them, STEM rhymes with Collaboration, Discovery, Impact, Expert guidance, Patient, Responsibility & Resilience.

👉 And for you — Science, Technology, Engineering and Mathematics rhyme with… ? Tell us in the comments!

Today we celebrate the International Day of Women and Girls in Science — a reminder of the brilliance, curiosity, and de...
11/02/2026

Today we celebrate the International Day of Women and Girls in Science — a reminder of the brilliance, curiosity, and determination driving innovation forward.
At Servier, our female scientists push boundaries every day, shaping the future of healthcare with passion and purpose.

For them, STEM rhymes with Alliance, Competence, Diversity, Evidence, Quality, Therapeutic adherence.

👉 And for you — Science, Technology, Engineering and Mathematics rhyme with… ? Share your word in the comments!

Adresse

50, Rue Carnot
Suresnes
92150

Téléphone

+33 1 55 72 60 00

Site Web

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Servier publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Partager

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Type

Our Story

Servier is an international pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France.

With a strong international presence in 149 countries and a turnover of € 4.2 billion in 2018, Servier employs 22.000 people worldwide.

Entirely independent, Servier reinvests 25% of its revenue (excluding generic drugs) in research and development and uses all its profits for development.